| February 2007 · Vol. 19, No. 02 COMMENT & CONTROVERSY
Let’s avoid another trip down the primrose path
|
Fast Track
“It behooves us to demand randomized, unbiased data [about pay for performance] that prove the worth of all this meddling”
|
|
“Pay for performance: We’ll be better off,” by Mark DeFrancesco, MD, MBA
Let me see if I understand the concept…. With pay for performance (P4P), the insurance companies, Medicaid, and Medicare are going to give us a “bonus” for doing all the things we have been doing (ie, Pap smears, STD testing, and postpartum visits, just to name a few). They are going to do this even though we have had to battle in the past just to receive a pittance of what is owed us for providing these services!?! Any physician who has had to negotiate reimbursement schedules for obstetrics and gynecology in the current environment has to see this as the ultimate irony.
|
